COVID-19 vaccines and mental distress

Francisco Pérez‐Arce · Daniel Bennett · Jill E. Darling · Arie Kapteyn · Kyla Thomas

150 citations0/0 files storedPLoS ONE

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

COVID-19 and Mental Health SARS-CoV-2 and COVID-19 Research Vaccine Coverage and Hesitancy

Abstract

BACKGROUND: The COVID-19 pandemic brought about large increases in mental distress. The uptake of COVID-19 vaccines is expected to significantly reduce health risks, improve economic and social outcomes, with potential benefits to mental health. PURPOSE: To examine short-term changes in mental distress following the receipt of the first dose of the COVID-19 vaccine. METHODS: Participants included 8,003 adults from the address-based sampled, nationally representative Understanding America Study (UAS), surveyed at regular intervals between March 10, 2020, and March 31, 2021 who completed at least two waves of the survey. Respondents answered questions about COVID-19 vaccine status and self-reported mental distress as measured with the four-item Patient Health Questionnaire (PHQ-4). Fixed-effects regression models were used to identify the change in PHQ-4 scores and categorical indicators of mental distress resulting from the application of the first dose of the COVID-19 vaccine. RESULTS: People who were vaccinated between December 2020 and March 2021 reported decreased mental distress levels in the surveys conducted after receiving the first dose. The fixed-effects estimates show an average effect of receiving the vaccine equivalent to 4% of the standard deviation of PHQ-4 scores (p-value<0.01), a reduction in 1 percentage point (4% reduction from the baseline level) in the probability of being at least mildly depressed, and of 0.7 percentage points (15% reduction from the baseline level) in the probability of being severely depressed (p-value = 0.06). CONCLUSIONS: Getting the first dose of COVID-19 resulted in significant improvements in mental health, beyond improvements already achieved since mental distress peaked in the spring of 2020.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 150 citations exist upstream.

References

2009An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4 2009A 4-item measure of depression and anxiety: Validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population 2021Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom 2021Factors Associated with COVID-19 Vaccine Hesitancy 2021Sleep problems during COVID-19 pandemic and its’ association to psychological distress: A systematic review and meta-analysis 2020Predictors of mental health during the Covid-19 pandemic in the US: Role of economic concerns, health worries and social distancing 2020Anxiety and Suicidal Thoughts During the COVID-19 Pandemic: Cross-Country Comparative Study Among Indonesian, Taiwanese, and Thai University Students 2021Motivation to Have COVID-19 Vaccination Explained Using an Extended Protection Motivation Theory among University Students in China: The Role of Information Sources

Cited by

2023Prevalence and variables associated with depression, anxiety, and stress among Chilean higher education students, post-pandemic 2022Scaling the changes in lifestyle, attitude, and behavioral patterns among COVID-19 vaccinated people: insights from Bangladesh 2021Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.